[Annual update of pulmonary infectious diseases in 2022].

Yang, Q Y; Qu, J M

Yang, Q Y; Qu, J M.

Yang QY; Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine;Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases Shanghai, Shanghai 200025, China.
Qu JM; Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine;Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases Shanghai, Shanghai 200025, China.

Zhonghua Jie He He Hu Xi Za Zhi ; 46(2): 168-171, 2023 Feb 12.

Статья в Китайский | MEDLINE | ID: covidwho-2246531

ABSTRACT

ABSTRACT

In 2022, coronavirus disease 2019 (COVID-19) remains rampant across the world. Several remarkable studies concerning pulmonary infectious diseases have been published during this pandemic. This review summarized the representative academic and translational medical progress over the past year (from October 1, 2021, to September 30, 2022), including COVID-19, community/hospital-acquired pneumonia, tuberculosis, and other respiratory viral infections.

Тема - темы

Полный текст

Печатать

XML

PubMed Links

Search on Google

Полный текст: Имеется в наличии Коллекция: Международные базы данных база данных: MEDLINE Основная тема: Pneumonia / Communicable Diseases / Community-Acquired Infections / Influenza, Human / COVID-19 Тип исследования: Наблюдательное исследование Пределы темы: Люди Язык: Китайский Журнал: Zhonghua Jie He He Hu Xi Za Zhi Год: 2023 Тип: Статья Аффилированная страна: Cma.j.cn112147-20221110-00890

Документы, близкие по теме

MEDLINE

LILACS

LIS

Полный текст

Печатать

XML

PubMed Links

Search on Google